Bio-Rad Labs (BIO) Tops Q1 EPS by 55c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $281.11 --0%
Revenue Growth %: -4.3%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -4.3%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.65, $0.55 better than the analyst estimate of $1.10. Revenue for the quarter came in at $554 million versus the consensus estimate of $549.56 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
